Endometrial Ablation Device Market - By Product, By End Use - Global Forecast 2025 - 2034

Endometrial Ablation Device Market Size

The global endometrial ablation device market size was estimated at USD 1.27 billion in 2024. The market is expected to grow from 1.33 billion in 2025 to 2.14 billion in 2034, at a CAGR of 5.4%. Endometrial ablation is a medical procedure used to treat heavy menstrual bleeding which is also known as menorrhagia. During this procedure, the lining of the uterus known as the endometrium is removed, which helps to reduce or stop the heavy bleeding. It is typically done when other treatments for heavy periods haven’t worked.
 

The endometrial ablation devices market is experiencing significant growth, stimulated by factors such as the increasing prevalence of heavy menstrual bleeding (HMB) and a global shift towards minimally invasive procedures. Heavy menstrual bleeding (HMB) is a condition characterized by excessively heavy or prolonged menstrual periods that can interfere with a woman's daily activities and quality of life. It is often associated with underlying medical conditions such as fibroids, endometriosis, or hormonal imbalances. For instance, a study published in the National Center for Biotechnology Information (NCBI) in 2023 stated that the prevalence of HMB among women aged 15-54 years was 24.1%.
 

The factors associated with HMB include age, use of hormonal contraceptives, which is estimated to reach USD 40 billion by 2032, low hemoglobin levels, and the presence of uterine fibroids.  Thus, this trend is highlighting the need for effective solutions to manage HMB and improve women's health and quality of life, thereby accelerating the demand for endometrial ablation devices. Additionally, the increasing inclination towards minimally invasive methods for the treatments of gynecological disorders, including HMB, is a major factor propelling the growth of endometrial ablation device markets. Endometrial ablation technique offers less invasive, safer alternative, and quicker recovery time as compared to conventional surgeries such as hysterectomy, making endometrial ablation technique more attractive among the patients and healthcare professionals.
 

Moreover, abnormal uterine bleeding (AUB) can significantly impact the daily lives of women, affecting their physical health and overall well-being. Women experiencing heavy menstrual bleeding frequently indicate decreased productivity in both work and school, as well as facing social and emotional difficulties. Research published in Obstetrics and Gynecology found that 30% to 50% of women suffering from AUB face considerable interference in their daily life because of symptoms such as severe bleeding, pain, and exhaustion. These disruptions not only affect their professional and educational lives but also take a toll on their mental and emotional well-being, underscoring the need for effective and accessible treatment options such as endometrial ablation, thereby accelerating the market growth.
 

Endometrial Ablation Device Market Trends

• The advancements in endometrial ablation technologies have improved the efficacy and safety of these treatments. Modern devices utilize various energy sources, including radiofrequency, plasma energy, and thermal methods, to ablate the endometrial lining efficiently. For example, the Minerva Endometrial Ablation System employs PlasmaSense technology, delivering consistent ablation depth without direct tissue contact, hence improving patient outcomes.
   
• Thus, these developments in treatment are enhancing women's health outcome and meeting an increasing need for more accessible and effective care, thereby stimulating the market growth.
   
• Moreover, the rising prevalence of gynecological disorders such as polycystic ovary syndrome (PCOS) and menorrhagia is greatly impacting the need for effective treatments such as endometrial ablation. For instance, the World Health Organization (WHO) in 2025 estimates that PCOS impacts approximately 6 –13% of women of reproductive age worldwide, leading to an increased occurrence of abnormal uterine bleeding and associated symptoms.
   
• These situations frequently result in excessive menstrual bleeding, hormonal discrepancies, and reproductive problems, making proper health management crucial. With the rising number of women diagnosed with these conditions, the demand for treatments such as endometrial ablation, which offers a minimally invasive and effective remedy for abnormal uterine bleeding is escalating.
   

Endometrial Ablation Device Market Analysis

Based on product, the market is segmented into cryoablation, radiofrequency ablation, hydrothermal ablation, thermal balloon, microwave ablation, hysteroscopy devices, and other products. The market was estimated at USD 1.3 billion in 2024. The radiofrequency ablation segment held revenue of USD 736.4 million in 2024, and the segment is poised for significant growth at a CAGR of 5.6% during the forecast period. This expansion is fueled by the rising preference for minimally invasive techniques, which provide patients with quicker recovery times and reduced complication rates as compared to conventional surgical approaches.
 

• Radiofrequency ablation devices serve to deliver radio frequency energy and eliminate the tissue that lines the uterus i.e. the endometrium. These devices minimize the likelihood of infection.
   
• The significant market share of radiofrequency endometrial ablation devices is influenced by factors such as excellent safety and quick recovery, growing awareness of this technique in developing nations, and strong preference among various healthcare providers.
   
• In addition to the benefits of the devices, the factors such as rising occurrence of cervical cancer, menorrhagia, and various gynecologic disorders further contributing to the expansion of the segment.
   

Based on end use, the endometrial ablation device market is segmented into hospitals, clinics, and ambulatory surgical centers. Clinics segment held a revenue share of 50.5% in 2024 and is projected for significant growth to reach USD 1.1 billion by 2034.
 

• Clinics are increasingly becoming a preferred setting for endometrial ablation procedures due to their ability to provide more personalized care.
   
• For instance, as per the study published by the National Library of Medicine reported that endometrial ablation procedures were successfully performed in an outpatient setting, with high completion rates and patient satisfaction. The procedure was completed in 97% of cases, with satisfaction rates ranging from 80% to 95%.
   
• Additionally, a report from the Australian Commission on Safety and Quality in Health Care (ACSQHC)in June 2024 stated that there is a 10% increase in the national rate for endometrial ablation over nine years, from 2013–14 to 2021–22. Therefore, as the rate of endometrial ablation increases so does the adoption of the technological advanced endometrial ablation devices among the clinics is anticipated to rise.
   
• In addition, clinics in larger cities have high patient turnover owing to referrals from family doctors, which in turn boosts the demand in these settings, propelling the growth of the segment.
   

The U.S. endometrial ablation device market is forecasted to reach USD 788.2 million by 2034.
 

• The availability of highly skilled healthcare professionals with specialization in women’s health and gynecology is significantly contributing to the market growth in the country.
   
• For instance, in May 2022, the U.S. Bureau of Labor Statistics reported approximately 19,820 obstetricians and gynecologists in the country.
   
• Moreover, technological advancements in endometrial ablation devices, along with improved education and awareness about minimally invasive procedures for the treatment of gynecological disorders, are further fueling the growth of the endometrial ablation market in the country.
   

Europe:

The endometrial ablation device market in the UK is projected to grow significantly from 2025 to 2034.
 

• The countries well established healthcare system and the rising demand for advanced ablation procedures are the key factors propelling the growth of the market in the country.
   
• Moreover, the increasing awareness regarding advanced ablation procedures, particularly among women aged 35 to 45, is further solidifying the growth of the market in the country.
   
• For instance, as per the data from PubMed, endometrial ablation is rapidly becoming a popular procedure, especially among women aged 35 to 45 years. The increasing awareness of the procedure's benefits in this age group is stimulating its adoption.
   

Asia Pacific:

The endometrial ablation device market in the Japan is projected to grow significantly from 2025 to 2034
 

• This growth is stimulated by several key factors including the prevalence of endometriosis and the increasing acceptance of minimally invasive treatments.
   
• For instance, a study published by PubMed in 2022 found that 88% of patients diagnosed with endometriosis experienced menstrual pain. Additionally, approximately 9.4% of Japanese women of reproductive age are affected by endometriosis.
   
• Therefore, as the prevalence of endometriosis increases in the country so does the  adoption of minimally invasive gynecological treatments, such as endometrial ablation, among women.
   
• With the rising demand for minimally invasive procedures and the growing awareness of endometrial ablation's benefits, Japan's market for these devices is expected to expand significantly, contributing to improved healthcare outcomes for women.
   

Middle East and Africa:

The endometrial ablation device market in the Saudi Arabia is projected to grow significantly from 2025 to 2034.
 

• The growth of the market is highly influenced by the increasing investment in healthcare infrastructure, including advanced medical device, such as endometrial ablation device is propelling the growth of the market in the country.
   
• For instance, Saudi Arabia's Vision 2030 includes significant investments in healthcare infrastructure, which are aimed at enhancing the quality and accessibility of medical services including endometrial ablation treatment across the country.
   
• Thus, these initiatives is aimed to enhance the quality and adoption of high quality medical technologies such as endometrial ablation, establishing the nation as a significant contributor in the healthcare environment of the Middle East and Africa.
   

Endometrial Ablation Device Market Share

The market is highly competitive with key players and new entrants constantly working to offer new products. In terms of revenue, the market share lies with the top five players which comprise Boston Scientific, Hologic, Medtronic, Minerva Surgical, and the Cooper Companies accounting for approximately 45% of the total market share. As part of their strategy these players develop new technologies to enhance the effectiveness and safety of their devices, while also improving patient outcomes. Furthermore, these firms are focusing on improving and modifying existing product lines to meet evolving healthcare needs. Moreover, strategic collaboration with healthcare professionals for advancing product development. The development of public awareness and educational initiatives will encourage patients to seek treatments, enabling market players to strengthen their position in this growing sector.
 

Endometrial Ablation Device Market Companies

Some of the eminent market participants operating in the endometrial ablation device industry include:

• AEGEA Medica
• AngioDynamics
• Boston Scientific
• Hologic
• IDOMAN-MED
• Karl Storz
• Medtronic
• Minerva Surgical
• Olympus
• Richard Wolf
• The Cooper Companies
• Veldana Medical
   
• Medtronic has a strong global presence, with its products being sold in more than 150 countries.
   
• CooperCompanies has strong financial growth, reporting fourth quarter 2024 revenues of USD 1,018.4 million, marking a 10% increase compared to the same quarter in the previous year.
   

Endometrial Ablation Device Industry News:

• In January 2025, Hologic completed its previously announced acquisition of Gynesonics, a private medical device company focused on the development of minimally invasive solutions for women’s health. This acquisition is anticipated to strengthen the company’s product portfolio and increase the revenue of the company.
   
• In February 2023, Hologic announced approval of the NovaSure V5 global endometrial ablation (GEA) device in Canada and Europe. This approval allowed the company to strengthen its market presence, attract new clientele, and enhance its competitive position in the market.
   

The endometrial ablation device market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Cryoablation 
• Radiofrequency ablation
• Hydrothermal ablation
• Thermal balloon
• Microwave ablation
• Hysteroscopy devices
• Other products

Market, By End Use

• Hospitals
• Clinics
• Ambulatory surgical centers

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands 
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE